T. M. Terekhova

T. M. Terekhova

Auto-generated profile, based on publicly available information

T. M. Terekhova

Novosibirsk Research Institute of Traumatology and Orthopedics n.a. Ya.L. Tsivyan of Minzdrav of Russia

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2023 in Siberian Scientific Medical Journal
Verified
Journal Article
Open access
PDF file
ALAlexander Lykov
Alexander Lykov
SBS. N. Belogorodtsev
S. N. Belogorodtsev
ENE. K. Nemkova
E. K. Nemkova
AVA. Vetlugina
A. Vetlugina
TTT. M. Terekhova
T. M. Terekhova
ЯШЯ. Ш. Шварц
Я. Ш. Шварц
Cells of innate immunity, mainly monocytes/macrophages, form a long-term nonspecific immunological memory during the initial encounter with the pathogen, the so-called trained immunity. Mevalonate pathway metabolites play an important role in the formation of trained immunity. The aim of this investigation was to study the effect of modulators of mevalonate pathway, mevalonate and zoledronate, on the formation of trained immunity in human and animal monocytes/ macrophages.Material and methods. Human monocyte-like cell lines THP-1 and U-937, peritoneal macrophages of BALB/c mice were used. Trained immunity was induced in vitro by incubation of THP-1 and U-937 monocyte-like cell lines for 24 and 72 hours with inactivated Mycobacteria of BCG vaccine strain, and in vivo by intraperitoneal administration of BCG to BALB/c mice with isolation of peritoneal macrophages on day 7 after infection (lag phase). Cell hyperreactivity was assessed by response to a second stimulus with bacterial lipopolysaccharide (LPS) and mevalonate, zoledranate in the presence or absence of LPS. Lactate, cytokine (IL-1β, TNF-α, IL-10), nitric oxide and glucose level was measured in conditioned media from cells.Results and discussion. The study showed that monocyte-like cell lines THP-1 and U-937 responded differently by cytokine production, lactate, and glucose consumption to BCG stimulus in the presence or absence of lag phase. Mevalonate and zoledronate alone or in combination with LPS also stimulated cytokine production in different ways. The presence of lag phase for human monocyte-like cells is essential for the level of cytokine production and glucose consumption. Peritoneal macrophages have been shown to enhance pro-inflammatory cytokine production in response to LPS, mevalonate, and zoledronate.Conclusions. Mevalonate and zoledronate induce trained immunity in monocytes/macrophages.

1 June 2023 in Medical Immunology (Russia)
Verified
Journal Article
Open access
PDF file
ALAlexander Lykov
Alexander Lykov
SBS. N. Belogorodtsev
S. N. Belogorodtsev
ЕNЕ. К. Nemkova
Е. К. Nemkova
АVА. Vetlugina
А. Vetlugina
ТTТ. М. Terekhova
Т. М. Terekhova
ЯШЯ. Ш. Шварц
Я. Ш. Шварц
Innate immune cells (monocytes/macrophages, NK) can also develop immune memory, which means that these cells are trained after their first encounter with pathogens so that they exhibit a nonspecific immunological response to the same or another pathogen. Bacilli Calmette–Gu rin (BCG) induces nonspecific innate memory (trained immunity) in innate immune cells. We examined nonspecific innate memory in macrophages of BALB/c mice in response to mycobacteria with or without the RD1 region in the genome. Mice were immunized with BCG vaccine, and peritoneal macrophages were isolated on day 7, and then stimulated with bacterial lipopolysaccharide, CFP-10, or ESAT-6. In addition, mice were immunized with Mycobacterium tuberculosis uro-BCG vaccine (RD1-) and Mycobacterium tuberculosis strain H37Rv (RD1+) subcutaneously or intravenously; peritoneal macrophages were isolated and stimulated with lipopolysaccharide on day 4. Alveolar macrophages were obtained from lung explants of mice infected with Mycobacterium tuberculosis strain H37Rv mice, were expanded to confluence 70-80% and further stimulated with lipopolysaccharide. Lactate, cytokines, and glucose levels were examined in conditioned macrophage medium. Peritoneal macrophages from mice primed with BCG vaccine were shown to increase IL-1b, TNFa, and lactate production in response to CFP-6 and ESAT-10 (p < 0.05). Of note is the fact that lipopolysaccharide also increased production of IL-1b, TNFa, and also increased glucose uptake by peritoneal macrophages primed with BCG vaccine (p < 0.05). Peritoneal macrophages primed with Uro-BCG were shown to increase spontaneous production of IL-1b and decrease spontaneous production of TNFa (p < 0.05). When macrophages were primed by subcutaneous or intravenous administration of Mycobacterium tuberculosis strain H37Rv differentially affected cytokine production, by decreasing IL-1b production and increasing TNFa and IL-10, was observed. In response to lipopolysaccharide, peritoneal macrophages increased IL-1b, TNFa, IL-10 production and glucose consumption (p < 0.05). The mode of priming of macrophages with Mycobacterium tuberculosis strain H37Rv also led to multidirectional levels of cytokine production. Alveolar macrophages were shown to retain trained immunity, as they produced elevated levels of IL-1b, TNFa, and IL-10 (p < 0.05). Thus, mouse macrophages formed a trained immunity phenotype in response to different types of mycobacteria, which persists for a long time after primary contact with the pathogen, particularly in alveolar macrophages.

29 January 2026 in Siberian Scientific Medical Journal
Verified
Journal Article
Open access
PDF file
TTT. M. Terekhova
T. M. Terekhova
PLPeter Mikhailovich Larionov
Peter Mikhailovich Larionov
ВЛВ. И. Ларькин
В. И. Ларькин
ASA. E. Simonovich
A. E. Simonovich
ASA. S. Shershever
A. S. Shershever
VSV. V. Stupak
V. V. Stupak
The dura mater plays a key role in protecting the central nervous system by providing mechanical and barrier functions. Various injuries, surgical interventions, and pathological conditions may require its repair or replacement. The use of synthetic implants or autografts often carries risks, including infections, allergic reactions, and rejection. In recent years, bacterial cellulose has gained attention as a biomaterial with unique properties that could significantly improve surgical outcomes. This review explores the potential of bacterial cellulose as a dura mater substitute and analyzes its advantages. A literature search was conducted in PubMed and Google Scholar (2014–2024), focusing on key studies of biocompatibility and neurosurgical applications. Keywords included bacterial nanocellulose, properties of bacterial nanocellulose, dura mater defects, biocompatibility. Out of 127 sources (in vitro, in vivo, and clinical studies), 32 articles were selected based on novelty, depth of research (mechanical properties, immune response, tissue regeneration), and relevance to dura mater repair. Priority was given to publications from the last decade (2014–2024), experimental in vivo models (rabbits, rats), and reviews on neurosurgical applications. A literature review has shown that bacterial cellulose is a promising biomaterial with unique properties, including high biocompatibility, hypoallergenicity, and the ability to modulate the immune response toward an anti-inflammatory phenotype. A key factor in its efficacy is thorough endotoxin removal, which minimizes inflammatory reactions. Bacterial cellulose demonstrates particular potential in experimental and clinical neurosurgery as a potential medical device for dura mater defect repair.